Effect of Continuous Glucose Monitoring System on Glycemic Control in Non-insulin-Treated Elderly People With Type 2 Diabetes

This study is testing whether continuous glucose monitoring (CGM) — a small sensor worn on the skin that tracks blood sugar throughout the day — can help older adults with type 2 diabetes achieve better blood sugar control compared to standard care. **You may be eligible if...** - You are 60 years or older - You have type 2 diabetes - You are taking two or more oral diabetes medications on a stable regimen for the past 3 months - Your HbA1c (a measure of blood sugar control over time) is between 7.5% and 10% - You own a smartphone compatible with the CGM device **You may NOT be eligible if...** - You are currently using insulin or a GLP-1 receptor agonist (e.g., semaglutide or liraglutide) - You have used a CGM device in the past 3 months - You have a skin condition or adhesive allergy that would prevent sensor use - You have dementia, severe psychiatric illness, or significant sensory impairment - You have planned surgery or procedures within the next 6 months that could interfere with the study Talk to your doctor to see if this trial is right for you.